TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Surgical Science Sweden AB
Closing information (x1000 EUR)
Closing information | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 72,117 | 35,864 | 10,441 |
Financial expenses | 1,751 | 2,244 | 31 |
Earnings before taxes | 18,707 | 6,434 | 1,959 |
EBITDA | 16,372 | 7,600 | |
Total assets | 417,814 | 388,987 | 47,051 |
Current assets | 74,259 | 60,322 | 13,290 |
Current liabilities | 27,489 | 22,722 | 3,116 |
Equity capital | 380,692 | 350,553 | 42,545 |
- share capital | 228 | 248 | 172 |
Employees (average) | 227 | 121 | 57 |
Financial ratios
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 91.1% | 90.1% | 90.4% |
Turnover per employee | 318 | 296 | 183 |
Profit as a percentage of turnover | 25.9% | 17.9% | 18.8% |
Return on assets (ROA) | 4.9% | 2.2% | 4.2% |
Current ratio | 270.1% | 265.5% | 426.5% |
Return on equity (ROE) | 4.9% | 1.8% | 4.6% |
Change turnover | 39,158 | 25,617 | 327 |
Change turnover % | 119% | 250% | 3% |
Chg. No. of employees | 106 | 64 | 12 |
Chg. No. of employees % | 88% | 112% | 27% |
Total value of public sale
Fiscal year | 2022/12 (consolidated) | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.